Table of Contents Table of Contents
Previous Page  5 / 1082 Next Page
Information
Show Menu
Previous Page 5 / 1082 Next Page
Page Background

ESTRO 36 CONTENT

SATURDAY 6 MAY 2017

Teaching Lecture

The role of radiotherapy in small cell lung cancer -current status and future developments ..............Abs. 1

Immunotherapy. ...................................................................................................................Abs. 2

MRI for RO physicists: what is what? QA geometrical distortions...................................................Abs. 3

Cavity Theory: separating the facts from the myths ...................................................................Abs. 5

High tech or low tech for metastatic disease, how does one decide and what is the cost-benefit? . ....Abs. 6

Gene editing: How this technique can be used to study radiation responses? .................................Abs. 7

Target delineation and target definition for PBI . .....................................................................Abs. 8-9

Joint Symposium

ESTRO-ASTRO: Cutting edge combined modality therapies (Focus on NSCLC) ......................... Abs. 10-13

Symposium with Proffered Papers

Radiotherapy plus immunotherapy combination: rationale and results so far . ......................... Abs. 14-18

Joint symposium

ESTRO-AAPM: New technological and computational developments in particle therapy ............. Abs. 19-21

Symposium

T imaging, new developments ......................................................................................... Abs. 22-24

High tech or low tech for metastatic disease, how does one decide

and what is the cost-benefit? . ......................................................................................... Abs. 25-27

Symposium with Proffered Papers

Novel approaches in heart / lung matters .......................................................................... Abs. 28-31

Symposium

Expanding brachytherapy indications ................................................................................ Abs. 32-34

Proffered Papers

Radiobiological modeling . ............................................................................................... Abs. 35-41

Poster Viewing

Session 1: Haematology / Paediatrics / Sarcoma ................................................................ Abs. 42-50

Proffered Papers

Joint Clinical - GEC ESTRO on cervix cancer ....................................................................... Abs. 51-56

Symposium

Response adapted treatment ........................................................................................... Abs. 57-59

Proffered Papers

Dosimetry and detector development for particle therapy .................................................... Abs. 60-65

Quantitative and functional imaging ................................................................................. Abs. 66-71

Improvements in positioning and motion management ........................................................ Abs. 72-77

Symposium with Proffered Papers

Novel approaches in gut matters ...................................................................................... Abs. 78-80

Proffered Papers

Skin . ........................................................................................................................... Abs. 81-86

Poster Viewing

Session 2: Palliative and health services research ............................................................... Abs. 87-93

Award Lecture

Van der Schueren Award lecture ...........................................................................................Abs. 94

Iridium Award Lecture .........................................................................................................Abs. 95

Honorary Physicist Award Lecture . ........................................................................................Abs. 96

Symposium

The optimal approach to treat oligometastastic disease: different ways to handle

an indication quickly gaining acceptance ......................................................................... Abs. 97-100

Symposium with Proffered Papers

Targeting tumour heterogeneity ....................................................................................Abs. 101-105

Symposium

Innovations in ion beam therapy ...................................................................................Abs. 106-108

Imaging for therapeutic response / toxicity evaluation . ....................................................Abs. 109-111

Comprehensive motion management and immobilisation solutions in radiation therapy .........Abs. 112-114